1.A Proposal of the Establishment of Technology System of Review and Registration in Conformity with the Characteristics Traditional Chinese Medicine
World Science and Technology-Modernization of Traditional Chinese Medicine 2016;18(12):2031-2033
Thanks to the improving new drug approval system and the wide application of new technology in China,the development of traditional Chinese medicine (TCM) meets the golden opportunity at the best conditions.In the further research of new drugs,effective data mining of ancient literatures and clinical medication experience need paying more attention supported by research data of clinical efficacy of new Chinese drugs,as it is generally recognized,for the establishment of the approval system of syndrome types.In addition,we should prudently value the safety issues on TCM and improve the classification and registration of new Chinese drugs and drug approval in the future.Therefore,the research and development of modern drugs,evaluation standard and review experience of new Chinese drugs in the recent three decades need integrating for the establishment of the improvement of the technology system of drug review and registration in conformity with the characteristics of TCM of great significance in the clinical service and industrial development of TCM.
3.Prospective Clinical Study of Nephrotoxicity of Compound Decoction of Caulis Aristolochiae Manshuriensis
Traditional Chinese Drug Research & Clinical Pharmacology 2000;0(06):-
To investigate the possible nephrotoxicity of Compound Decoction of Caulis Aristolochiae Manshuriensis (CDCAM). Body weight, blood pressure, hemoglobin and renal functions, especially of urinary low-molecular weight protein in patients were observed before and after a short-term ( 0.05 ).[Conclusion]The nephrotoxicity of Caulis Aristolochiae Manshuriensis may be associated with the long-term over-dose administration and without TCM syndrome differentiation.
4.How to assess the quality of systematic review and meta-analysis
Junhua ZHANG ; Hongcai SHANG ; Boli ZHANG
Journal of Integrative Medicine 2008;6(4):337-40
Evidence-based medicine advocates that decision making should be based on the adequate evidence. High quality systematic review is an important source of information for clinicians, patients, governments and other decision makers in decision making. If reviewers couldn't master the correct method of systematic review or meta-analysis was misused, the inaccurate, biased or misleading outcomes would be produced. So understanding of the methods of evaluating the quality of systematic review and meta-analysis is helpful to make good use of the review's information.
6.Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice
Hongcai SHANG ; Boli ZHANG ; Youping LI
Journal of Integrative Medicine 2008;6(9):887-90
Unclear clinical orientation in practice has become one of the common problems with the effective application of famous and excellent Chinese herbal drugs, consequently restricting their development. The authors suggest that there are three aspects to be considered in dealing with this problem. Clinical evaluation and orientation of the famous and excellent Chinese herbal drugs is an important task, and it is also a requirement for the internationalization of traditional Chinese medicine. Literature evaluation-pharmacology research-clinical expertise analysis method will establish a theoretical basis and method for post-marketing development of famous and excellent Chinese patent drugs.
8.Legal framework of drug packaging wastes recycling in China
Daoxian YANG ; Boli CHEN ; Hengdi ZHANG
Chinese Journal of Hospital Administration 2013;(3):231-235
Authors defined the concept of drug packaging wastes,and analyzed the current administration of such waste recycling in China.With reference to experiences of other countries and Taiwan,the paper proposed to refine the legal framework for recycling drug packaging waste in China,by categorizing to set up the categorized recycling mechanism,and by refining the process to build the reverse logistics recycling system.
9.In - Vitro Protective Effect of Qingnao Yizhi Formula on Glutanic-Acid-Induced Neuron Inury
Jianxun MEI ; Boli ZHANG ; Rong LU
Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(04):-
Objective: To explore the therapeutic mechanism of Qingnao Yizhi Formula (QYF) for vascular dementia and multi - infarct dermentia. Methods: In- vitro rabbit neuron culture was utilized to investigate the effect of QYF on glutamic - acid - induced neuron injury. Results: QYF could increase the survival rate of iniured neuron(P
10.Determination of Saponins Content in Compound Danshen Prescription by HPLC
Guixiang PAN ; Xiumei GAO ; Boli ZHANG
Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(02):-
Objective To develop a method for the determination of four saponins of panax notoginseng in Compound Dan-shen Prescription (CDP) by HPLC. Methods The conditions for the experiment were: determination of notoginsenoside R1, ginsenoside Rg1 and ginsenoside Re with acetonitrile - 0. 05 % phosphoric acid (19 : 81) as mobile phase and the detection wave at 203nm, determination of ginsenoside Rb1 with acetonitrile - water (33 : 67) as mobile phase and the detection wave at 203nm. Results A good linearity for notoginsenoside R1 was in the range of 0. 24 ~ 3. 6?g ( r = 0. 9997), 1. 2 ~ 18?g (r = 0. 9994) for ginsenoside Rg1, 0. 08 ~ 1. 2?g(r = 0. 9997) for ginsenoside Re and 0. 25-3. 72?g (r = 0. 9998) for ginsenoside Rb1. The stability of the four saponins is well kept at 4℃ for four months. Conclusion This method is simple, rapid, accurate and with good reproducibility and can be used for the quality control of CDP.